For the first time in decades, the HHS OIG has published a new and significant compliance program guidance document for those participating in the healthcare industry. The 91-page document — "General Compliance Program Guidance" — contains vital information for compliance officers and other health professionals. This session will focus on the five most important takeaways for practice managers, healthcare executives, boards and clinical leaders. The presentation will examine the compliance expectations of those in the C-suite and board room and offer a fresh take on consequences and incentives, including new entrants into the healthcare industry. Attendees will learn the need for "risk assessment" as one of the core seven elements of an effective compliance program, as well as adaptations for small and large entities. Finally, the session will detail OIG’s focus on clinical quality of care and medical necessity. The session will use case studies and real-life enforcement examples to demonstrate why each of these five areas is essential for leaders to understand.
Learning Objectives:
Point out the key takeaways from the November 2023 HHS OIG general compliance program guidance
Examine case studies and the financial, legal and reputational consequences of non-compliance with healthcare laws and regulations
Outline strategies, tools and resources for successfully addressing the compliance expectations discussed
